Supriya Lifescience has announced a board meeting to be held on February 09, 2026, to consider and approve the unaudited financial results for the quarter and nine months ending December 31, 2025. The trading window for dealing in the company’s securities will be closed until 48 hours after the declaration of the unaudited financial results.
Board Meeting Announcement
A meeting of the Board of Directors of Supriya Lifescience is scheduled for February 09, 2026. The primary agenda is to review and approve the unaudited financial results for Q3 (October-December) and the nine-month period ending December 31, 2025.
Trading Window Closure
In compliance with the company’s code of conduct, the trading window for designated persons and their immediate relatives is closed from January 01, 2026, until 48 hours after the declaration of the unaudited financial results on February 09, 2026. This restriction applies to trading in the securities of Supriya Lifescience.
Source: BSE
